{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:32:11Z","timestamp":1787682731826,"version":"build-2784847793"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Commission of Guangdong Province","award":["A2020177"],"award-info":[{"award-number":["A2020177"]}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["202201010764"],"award-info":[{"award-number":["202201010764"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20231219"],"award-info":[{"award-number":["20231219"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","award":["\"Climbing Plan\" No. pdjh2023b0279"],"award-info":[{"award-number":["\"Climbing Plan\" No. pdjh2023b0279"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91038-4","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:16:40Z","timestamp":1740467800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme"],"prefix":"10.1038","volume":"15","author":[{"given":"Xi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"91038_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller, K. D. et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J. Clin. 71, 381\u2013406 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"91038_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020. Neuro Oncol. 25, iv1\u2013iv99 (2023).","journal-title":"Neuro Oncol."},{"key":"91038_CR3","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol. 24, v1\u2013v95 (2022).","journal-title":"Neuro Oncol."},{"key":"91038_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11060-013-1103-9","volume":"113","author":"P Yang","year":"2013","unstructured":"Yang, P. et al. Management and survival rates in patients with glioma in China (2004\u20132010): A retrospective study from a single-institution. J. Neurooncol. 113, 259\u2013266 (2013).","journal-title":"J. Neurooncol."},{"key":"91038_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang, N. et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat. Commun. 13, 1511 (2022).","journal-title":"Nat. Commun."},{"key":"91038_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI89587","volume":"127","author":"S Osuka","year":"2017","unstructured":"Osuka, S. & Van Meir, E. G. Overcoming therapeutic resistance in glioblastoma: The way forward. J. Clin. Invest. 127, 415\u2013426 (2017).","journal-title":"J. Clin. Invest."},{"key":"91038_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. et al. Management of glioblastoma: State of the art and future directions. CA Cancer J. Clin. 70, 299\u2013312 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"91038_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo, R. et al. The role of alternative splicing in cancer: From oncogenesis to drug resistance. Drug Resist. Updat. 53, 100728 (2020).","journal-title":"Drug Resist. Updat."},{"key":"91038_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nature05304","volume":"444","author":"J Ule","year":"2006","unstructured":"Ule, J. et al. An RNA map predicting Nova-dependent splicing regulation. Nature 444, 580\u2013586 (2006).","journal-title":"Nature"},{"key":"91038_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Qian, J., Gu, C. & Yang, Y. Alternative splicing and cancer: A systematic review. Signal Transduct. Target Ther. 6, 78 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"91038_CR11","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","volume":"20","author":"H Climente-Gonzalez","year":"2017","unstructured":"Climente-Gonzalez, H., Porta-Pardo, E., Godzik, A. & Eyras, E. The functional impact of alternative splicing in cancer. Cell Rep. 20, 2215\u20132226 (2017).","journal-title":"Cell Rep."},{"key":"91038_CR12","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.jmb.2018.03.028","volume":"430","author":"J Zhou","year":"2018","unstructured":"Zhou, J., Zhao, S. & Dunker, A. K. Intrinsically disordered proteins link alternative splicing and post-translational modifications to complex cell signaling and regulation. J. Mol. Biol. 430, 2342\u20132359 (2018).","journal-title":"J. Mol. Biol."},{"key":"91038_CR13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nsmb.3317","volume":"23","author":"RJ Weatheritt","year":"2016","unstructured":"Weatheritt, R. J., Sterne-Weiler, T. & Blencowe, B. J. The ribosome-engaged landscape of alternative splicing. Nat. Struct. Mol. Biol. 23, 1117\u20131123 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"91038_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley, R. K. & Anczukow, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer 23, 135\u2013155 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"91038_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41419-022-05470-9","volume":"14","author":"OM Ivanova","year":"2023","unstructured":"Ivanova, O. M. et al. Non-canonical functions of spliceosome components in cancer progression. Cell Death Dis. 14, 77 (2023).","journal-title":"Cell Death Dis."},{"key":"91038_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12935-023-03094-3","volume":"23","author":"S Choi","year":"2023","unstructured":"Choi, S., Cho, N., Kim, E. M. & Kim, K. K. The role of alternative pre-mRNA splicing in cancer progression. Cancer Cell Int. 23, 249 (2023).","journal-title":"Cancer Cell Int."},{"key":"91038_CR17","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1038\/s41388-021-01947-7","volume":"40","author":"R Cheng","year":"2021","unstructured":"Cheng, R. et al. A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients. Oncogene 40, 5441\u20135450 (2021).","journal-title":"Oncogene"},{"issue":"211\u2013224","key":"91038_CR18","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles, A. et al. Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell 34(211\u2013224), e216 (2018).","journal-title":"Cancer Cell"},{"key":"91038_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/CM9.0000000000000542","volume":"133","author":"F Qi","year":"2020","unstructured":"Qi, F. et al. Significance of alternative splicing in cancer cells. Chin. Med. J. (Engl) 133, 221\u2013228 (2020).","journal-title":"Chin. Med. J. (Engl)"},{"key":"91038_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.trecan.2020.12.015","volume":"7","author":"Z Liu","year":"2021","unstructured":"Liu, Z. & Rabadan, R. Computing the role of alternative splicing in cancer. Trends Cancer 7, 347\u2013358 (2021).","journal-title":"Trends Cancer"},{"key":"91038_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41467-022-28253-4","volume":"13","author":"R Siddaway","year":"2022","unstructured":"Siddaway, R. et al. Splicing is an alternate oncogenic pathway activation mechanism in glioma. Nat. Commun. 13, 588 (2022).","journal-title":"Nat. Commun."},{"key":"91038_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103691","volume":"28","author":"D Li","year":"2023","unstructured":"Li, D., Yu, W. & Lai, M. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing. Drug Discov. Today 28, 103691 (2023).","journal-title":"Drug Discov. Today"},{"key":"91038_CR23","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","volume":"44","author":"MA Havens","year":"2016","unstructured":"Havens, M. A. & Hastings, M. L. Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res. 44, 6549\u20136563 (2016).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s43018-022-00384-z","volume":"3","author":"RF Stanley","year":"2022","unstructured":"Stanley, R. F. & Abdel-Wahab, O. Dysregulation and therapeutic targeting of RNA splicing in cancer. Nat. Cancer 3, 536\u2013546 (2022).","journal-title":"Nat. Cancer"},{"key":"91038_CR25","doi-asserted-by":"crossref","unstructured":"Patro, I., Sahoo, A., Nayak, B. R., Das, R., Majumder, S., & Panigrahi, G. K. Nonsense-mediated mRNA decay: Mechanistic insights and physiological significance. Mol. Biotechnol. (2023).","DOI":"10.1007\/s12033-023-00927-4"},{"key":"91038_CR26","doi-asserted-by":"publisher","first-page":"1152087","DOI":"10.3389\/fonc.2023.1152087","volume":"13","author":"S Araki","year":"2023","unstructured":"Araki, S., Ohori, M. & Yugami, M. Targeting pre-mRNA splicing in cancers: Roles, inhibitors, and therapeutic opportunities. Front Oncol. 13, 1152087 (2023).","journal-title":"Front Oncol."},{"key":"91038_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.molonc.2016.08.001","volume":"10","author":"FJ de Miguel","year":"2016","unstructured":"de Miguel, F. J. et al. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer. Mol. Oncol. 10, 1437\u20131449 (2016).","journal-title":"Mol. Oncol."},{"key":"91038_CR28","doi-asserted-by":"crossref","unstructured":"Munkley, J., Li, L., Krishnan, S. R. G., Hysenaj, G., Scott, E., Dalgliesh, C., Oo, H. Z., Maia, T. M., Cheung, K., Ehrmann, I., et al. Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer. Elife 8 (2019).","DOI":"10.7554\/eLife.47678"},{"key":"91038_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/0008-5472.CAN-09-2703","volume":"70","author":"M Dutertre","year":"2010","unstructured":"Dutertre, M. et al. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res. 70, 896\u2013905 (2010).","journal-title":"Cancer Res."},{"key":"91038_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2164-7-325","volume":"7","author":"PJ Gardina","year":"2006","unstructured":"Gardina, P. J. et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7, 325 (2006).","journal-title":"BMC Genomics"},{"key":"91038_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: An R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma patients. Genom. Proteom. Bioinform. 19, 1\u201312 (2021).","journal-title":"Genom. Proteom. Bioinform."},{"key":"91038_CR33","doi-asserted-by":"publisher","first-page":"D1196","DOI":"10.1093\/nar\/gkac955","volume":"51","author":"S Wu","year":"2023","unstructured":"Wu, S. et al. ASCancer Atlas: A comprehensive knowledgebase of alternative splicing in human cancers. Nucleic Acids Res. 51, D1196\u2013D1204 (2023).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR34","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1186\/s12885-021-08681-z","volume":"21","author":"Y Li","year":"2021","unstructured":"Li, Y. & Guo, D. Genome-wide profiling of alternative splicing in glioblastoma and their clinical value. BMC Cancer 21, 958 (2021).","journal-title":"BMC Cancer"},{"key":"91038_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","volume":"23","author":"M Seiler","year":"2018","unstructured":"Seiler, M. et al. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep. 23, 282-296 e284 (2018).","journal-title":"Cell Rep."},{"key":"91038_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ebiom.2018.09.021","volume":"36","author":"Y Xiong","year":"2018","unstructured":"Xiong, Y. et al. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data. EBioMedicine 36, 183\u2013195 (2018).","journal-title":"EBioMedicine"},{"key":"91038_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/humu.21609","volume":"33","author":"F Piva","year":"2012","unstructured":"Piva, F., Giulietti, M., Burini, A. B. & Principato, G. SpliceAid 2: A database of human splicing factors expression data and RNA target motifs. Hum. Mutat. 33, 81\u201385 (2012).","journal-title":"Hum. Mutat."},{"key":"91038_CR38","unstructured":"Gene Ontology, C., Aleksander, S. A., Balhoff, J., Carbon, S., Cherry, J. M., Drabkin, H. J., Ebert, D., Feuermann, M., Gaudet, P., Harris, N. L., et al. The gene ontology knowledgebase in 2023. Genetics 224 (2023)."},{"key":"91038_CR39","doi-asserted-by":"crossref","unstructured":"Tay, J. K., Narasimhan, B., & Hastie, T. Elastic net regularization paths for all generalized linear models. J. Stat. Softw. 106. (2023)","DOI":"10.18637\/jss.v106.i01"},{"key":"91038_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"91038_CR41","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR42","doi-asserted-by":"crossref","unstructured":"Hu, F. F., Liu, C. J., Liu, L. L., Zhang, Q., & Guo, A. Y. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform. 22 (2021).","DOI":"10.1093\/bib\/bbaa176"},{"key":"91038_CR43","doi-asserted-by":"crossref","unstructured":"Maeser, D., Gruener, R. F., & Huang, R. S. oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 22 (2021).","DOI":"10.1093\/bib\/bbab260"},{"key":"91038_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky888","volume":"47","author":"N Saraiva-Agostinho","year":"2019","unstructured":"Saraiva-Agostinho, N. & Barbosa-Morais, N. L. psichomics: Graphical application for alternative splicing quantification and analysis. Nucleic Acids Res. 47, e7 (2019).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-0716-0301-7_10","volume":"2117","author":"N Saraiva-Agostinho","year":"2020","unstructured":"Saraiva-Agostinho, N. & Barbosa-Morais, N. L. Interactive alternative splicing analysis of human stem cells using psichomics. Methods Mol. Biol. 2117, 179\u2013205 (2020).","journal-title":"Methods Mol. Biol."},{"key":"91038_CR46","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013W560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR47","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1101\/gr.1860604","volume":"14","author":"E Birney","year":"2004","unstructured":"Birney, E. et al. An overview of Ensembl. Genome Res. 14, 925\u2013928 (2004).","journal-title":"Genome Res."},{"key":"91038_CR48","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkac958","volume":"51","author":"FJ Martin","year":"2023","unstructured":"Martin, F. J. et al. Ensembl 2023. Nucleic Acids Res. 51, D933\u2013D941 (2023).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR49","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"91038_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred, R. et al. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 30, 187\u2013200 (2021).","journal-title":"Protein Sci."},{"key":"91038_CR51","doi-asserted-by":"publisher","first-page":"D648","DOI":"10.1093\/nar\/gkab1006","volume":"50","author":"N Del Toro","year":"2022","unstructured":"Del Toro, N. et al. The IntAct database: Efficient access to fine-grained molecular interaction data. Nucleic Acids Res. 50, D648\u2013D653 (2022).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR52","doi-asserted-by":"publisher","first-page":"D857","DOI":"10.1093\/nar\/gkr930","volume":"40","author":"L Licata","year":"2012","unstructured":"Licata, L. et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 40, D857-861 (2012).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR53","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"C UniProt","year":"2021","unstructured":"UniProt, C. UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480\u2013D489 (2021).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR54","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR55","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"91038_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR57","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"91038_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s11658-019-0162-0","volume":"24","author":"Y Bao","year":"2019","unstructured":"Bao, Y. et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol. Biol. Lett. 24, 38 (2019).","journal-title":"Cell Mol. Biol. Lett."},{"key":"91038_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106597","volume":"154","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas. Comput. Biol. Med. 154, 106597 (2023).","journal-title":"Comput. Biol. Med."},{"key":"91038_CR60","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ymthe.2021.08.011","volume":"30","author":"X Lin","year":"2022","unstructured":"Lin, X. et al. lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling. Mol. Ther. 30, 688\u2013702 (2022).","journal-title":"Mol. Ther."},{"key":"91038_CR61","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.molmed.2021.07.009","volume":"27","author":"NK Karamanos","year":"2021","unstructured":"Karamanos, N. K. et al. Extracellular matrix-based cancer targeting. Trends Mol. Med. 27, 1000\u20131013 (2021).","journal-title":"Trends Mol. Med."},{"key":"91038_CR62","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1111\/febs.12109","volume":"280","author":"A Wade","year":"2013","unstructured":"Wade, A. et al. Proteoglycans and their roles in brain cancer. FEBS J. 280, 2399\u20132417 (2013).","journal-title":"FEBS J."},{"key":"91038_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2019.07.012","volume":"62","author":"NA Espinoza-Sanchez","year":"2020","unstructured":"Espinoza-Sanchez, N. A. & Gotte, M. Role of cell surface proteoglycans in cancer immunotherapy. Semin. Cancer Biol. 62, 48\u201367 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"91038_CR64","doi-asserted-by":"crossref","unstructured":"Robichaud, N., Sonenberg, N., Ruggero, D., & Schneider, R. J. Translational control in cancer. Cold Spring Harb. Perspect. Biol. 11 (2019).","DOI":"10.1101\/cshperspect.a032896"},{"key":"91038_CR65","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11596-022-2638-9","volume":"42","author":"S Wu","year":"2022","unstructured":"Wu, S. et al. High expression of fibronectin 1 predicts a poor prognosis in glioblastoma. Curr. Med. Sci. 42, 1055\u20131065 (2022).","journal-title":"Curr. Med. Sci."},{"key":"91038_CR66","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1038\/s41467-024-47649-y","volume":"15","author":"TI Shaw","year":"2024","unstructured":"Shaw, T. I. et al. Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression. Nat. Commun. 15, 3732 (2024).","journal-title":"Nat. Commun."},{"key":"91038_CR67","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12920-019-0603-7","volume":"12","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Classification of glioma based on prognostic alternative splicing. BMC Med. Genomics 12, 165 (2019).","journal-title":"BMC Med. Genomics"},{"key":"91038_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.555632","volume":"10","author":"L Zhao","year":"2020","unstructured":"Zhao, L. et al. Comprehensive characterization of alternative mRNA splicing events in glioblastoma: Implications for prognosis, molecular subtypes, and immune microenvironment remodeling. Front. Oncol. 10, 555632 (2020).","journal-title":"Front. Oncol."},{"key":"91038_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.650153","volume":"11","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Identification and validation of a prognostic immune-related alternative splicing events signature for glioma. Front. Oncol. 11, 650153 (2021).","journal-title":"Front. Oncol."},{"key":"91038_CR70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3892\/ol.2020.12399","volume":"21","author":"J Qiu","year":"2021","unstructured":"Qiu, J. et al. Transcriptome analysis and prognostic model construction based on splicing profiling in glioblastoma. Oncol. Lett. 21, 138 (2021).","journal-title":"Oncol. Lett."},{"key":"91038_CR71","first-page":"4664955","volume":"2021","author":"B Zhang","year":"2021","unstructured":"Zhang, B., Wu, Q., Cheng, S. & Li, W. Systematic profiling of mRNA splicing reveals the prognostic predictor and potential therapeutic target for glioblastoma multiforme. J. Oncol. 2021, 4664955 (2021).","journal-title":"J. Oncol."},{"key":"91038_CR72","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1448329","volume":"7","author":"J DiDomenico","year":"2018","unstructured":"DiDomenico, J. et al. The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma. Oncoimmunology 7, e1448329 (2018).","journal-title":"Oncoimmunology"},{"key":"91038_CR73","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41467-021-22885-8","volume":"12","author":"Z Amoozgar","year":"2021","unstructured":"Amoozgar, Z. et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat. Commun. 12, 2582 (2021).","journal-title":"Nat. Commun."},{"key":"91038_CR74","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.18632\/aging.103147","volume":"12","author":"L Huang","year":"2020","unstructured":"Huang, L. et al. EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma. Aging (Albany NY) 12, 8397\u20138412 (2020).","journal-title":"Aging (Albany NY)"},{"key":"91038_CR75","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9038","volume":"8","author":"Y Tian","year":"2020","unstructured":"Tian, Y., Ke, Y. & Ma, Y. High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment. PeerJ 8, e9038 (2020).","journal-title":"PeerJ"},{"key":"91038_CR76","doi-asserted-by":"publisher","first-page":"1294029","DOI":"10.3389\/fncel.2023.1294029","volume":"17","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Impact of ferroptosis-related risk genes on macrophage M1\/M2 polarization and prognosis in glioblastoma. Front. Cell Neurosci. 17, 1294029 (2023).","journal-title":"Front. Cell Neurosci."},{"key":"91038_CR77","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/s12885-023-11222-5","volume":"23","author":"J Li","year":"2023","unstructured":"Li, J., Guo, Q. & Xing, R. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma. BMC Cancer 23, 727 (2023).","journal-title":"BMC Cancer"},{"key":"91038_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108430","volume":"216","author":"X Shan","year":"2020","unstructured":"Shan, X. et al. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling. Clin. Immunol. 216, 108430 (2020).","journal-title":"Clin. Immunol."},{"key":"91038_CR79","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/jcb.30173","volume":"123","author":"M Kulbay","year":"2022","unstructured":"Kulbay, M., Paimboeuf, A., Ozdemir, D. & Bernier, J. Review of cancer cell resistance mechanisms to apoptosis and actual targeted therapies. J. Cell Biochem. 123, 1736\u20131761 (2022).","journal-title":"J. Cell Biochem."},{"key":"91038_CR80","doi-asserted-by":"crossref","unstructured":"Paladini, J., Maier, A., Habazettl, J. M., Hertel, I., Sonti, R., & Grzesiek, S. The molecular basis of Abelson kinase regulation by its alphaI-helix. Elife 12 (2024).","DOI":"10.7554\/eLife.92324.3"},{"key":"91038_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.743738","volume":"12","author":"C Sun","year":"2021","unstructured":"Sun, C. et al. Identification of IGF2BP3 as an adverse prognostic biomarker of gliomas. Front. Genet. 12, 743738 (2021).","journal-title":"Front. Genet."},{"key":"91038_CR82","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/cas.12022","volume":"103","author":"DI Jin","year":"2012","unstructured":"Jin, D. I. et al. Expression and roles of Wilms\u2019 tumor 1-associating protein in glioblastoma. Cancer Sci. 103, 2102\u20132109 (2012).","journal-title":"Cancer Sci."},{"key":"91038_CR83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12031-016-0788-6","volume":"60","author":"Z Xi","year":"2016","unstructured":"Xi, Z. et al. WTAP expression predicts poor prognosis in malignant glioma patients. J. Mol. Neurosci. 60, 131\u2013136 (2016).","journal-title":"J. Mol. Neurosci."},{"key":"91038_CR84","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.18632\/aging.205666","volume":"16","author":"Q Ji","year":"2024","unstructured":"Ji, Q., Guo, Y., Li, Z. & Zhang, X. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma. Aging (Albany NY) 16, 5601\u20135617 (2024).","journal-title":"Aging (Albany NY)"},{"key":"91038_CR85","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1002\/j.1460-2075.1986.tb04575.x","volume":"5","author":"RJ Owens","year":"1986","unstructured":"Owens, R. J. & Baralle, F. E. Mapping the collagen-binding site of human fibronectin by expression in Escherichia coli. EMBO J. 5, 2825\u20132830 (1986).","journal-title":"EMBO J."},{"key":"91038_CR86","doi-asserted-by":"publisher","first-page":"12136","DOI":"10.1016\/S0021-9258(17)38997-4","volume":"260","author":"J Calaycay","year":"1985","unstructured":"Calaycay, J. et al. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin. J. Biol. Chem. 260, 12136\u201312141 (1985).","journal-title":"J. Biol. Chem."},{"key":"91038_CR87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/0929866530666221019162943","volume":"30","author":"C Chen","year":"2023","unstructured":"Chen, C. & Shen, Z. FN1 promotes thyroid carcinoma cell proliferation and metastasis by activating the NF-Kappa pathway. Protein Pept. Lett. 30, 54\u201364 (2023).","journal-title":"Protein Pept. Lett."},{"key":"91038_CR88","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10549-023-07032-9","volume":"201","author":"C Chen","year":"2023","unstructured":"Chen, C., Ye, L., Yi, J., Liu, T. & Li, Z. FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer. Breast Cancer Res. Treat. 201, 515\u2013533 (2023).","journal-title":"Breast Cancer Res. Treat."},{"key":"91038_CR89","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1007\/s12011-022-03510-1","volume":"201","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Fibronectin 1 as a key gene in the genesis and progression of cadmium-related bladder cancer. Biol. Trace Elem. Res. 201, 4349\u20134359 (2023).","journal-title":"Biol. Trace Elem. Res."},{"key":"91038_CR90","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033388","volume":"102","author":"J Ma","year":"2023","unstructured":"Ma, J., Chen, S., Su, M. & Wang, W. High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma. Medicine (Baltimore) 102, e33388 (2023).","journal-title":"Medicine (Baltimore)"},{"key":"91038_CR91","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41588-024-01872-x","volume":"56","author":"B Fair","year":"2024","unstructured":"Fair, B. et al. Global impact of unproductive splicing on human gene expression. Nat. Genet. 56, 1851\u20131861 (2024).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91038-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:47:04Z","timestamp":1740469624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91038-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91038-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"6716"}}